RBC Capital Reiterates Outperform on Colgate-Palmolive, Maintains $102 Price Target
Colgate-Palmolive Company
Colgate-Palmolive Company CL | 0.00 |
RBC Capital analyst Nik Modi reiterates Colgate-Palmolive (NYSE:
CL) with a Outperform and maintains $102 price target.
